CAD and bladder transitional cell carcinoma: CAD and POLD2 were significantly correlated in BLCA tumor samples; however, when restricted to patients administered cisplatin-based therapy, patient expressions became more tightly correlated (r = 0.45, P < 0.001 vs r = 0.61, P < 0.001, respectively; Figure 5E-5F).